Restech Srl
6
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models
Role: collaborator
Self-Management Of Asthma By Forced Oscillation Technique
Role: lead
Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies
Role: lead
Within-Breath Total Respiratory Input Impedance in Healthy Adult Subjects
Role: lead
Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device
Role: collaborator
Clinical Trials for Elderly Patients With Multiple Disease
Role: lead
All 6 trials loaded